Scientists are poised to launch a phase 3 paediatric clinical trial of Chinese manufacturer Sinovac Biotech’s coronavirus vaccine in SA, as part of an international study that aims to evaluate the efficacy of two doses of the Coronavac shot. The research is an important step towards obtaining regulatory approval for paediatric use of the vaccine.
The SA Health Products Regulatory Authority has so far only granted Coronavac emergency use authorisation for adults aged between 18 and 59 years. The jab is, however, authorised in China for children as young as three years...A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
I entrusted Dennismayson7 with my money since I took rush of investing my money with he platform, and since then I've recovered all I lost to scams. Get in touch with Dennismayson7 and get a good mentorship and safe trading.